orteronel: Clinical Trials

5 trials of orteronel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5

Follow orteronel: new trials by email Literature Review of orteronel trials Research Report on orteronel

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
TAK-700, Bicalutamide - Prostate Cancer
Phase 3CompletedSWOG Cancer Research Network13132013-03-082025-12-31
Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy
Orteronel, Placebo - Prostate Cancer
Phase 3CompletedSwiss Cancer Institute472012-09-012019-05-15
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
GnRH agonist, Anti-androgen, TAK-700 - Prostate Cancer
Phase 3CompletedRadiation Therapy Oncology Group2392012-05-012026-03-06
Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.
Orteronel, Prednisone, Orteronel Placebo - Prostate Cancer
Phase 3CompletedMillennium Pharmaceuticals, Inc.10992010-11-152018-12-19
Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer
Orteronel, Placebo, Prednisone - Prostate Cancer
Phase 3CompletedMillennium Pharmaceuticals, Inc.15602010-10-012017-05-17

Conditions studied

Prostatic Neoplasms (5)

Sponsors

Millennium Pharmaceuticals, Inc. (2)  ·  Radiation Therapy Oncology Group (1)  ·  SWOG Cancer Research Network (1)  ·  Swiss Cancer Institute (1)

Countries

United States (4)  ·  Canada (3)  ·  Australia (2)  ·  Belgium (2)  ·  Czechia (2)  ·  Finland (2)  ·  France (2)  ·  Greece (2)  ·  Italy (2)  ·  Netherlands (2)  ·  Poland (2)  ·  Spain (2)  ·  Switzerland (2)  ·  Austria (1)  ·  Belarus (1)

Top investigators

M. Dror Michaelson, MD, PhD (1)  ·  Neeraj Agarwal, M.D. (1)  ·  Richard Cathomas, MD (1)  ·  Silke Gillessen, Prof (1)

Results publications

PMID 26031410, PMID 29272162, PMID 25624429, PMID 25701170, PMID 27457964, PMID 35446628, PMID 37526936, PMID 38424319, PMID 38980676